Delivery Order SPE2DB25D3201-SPE2DB25FNTHM
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $12,446.16, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LAZCLUZE 240 MG TABLET 30S medical supplies. The contract, valued at $11,913.52, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary contracting agency. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6MRC, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, with a performance period ending on May 16, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,522.49, is for the supply of 4566848831 ! LAZCLUZE 80 MG TABLET 60S, a medical product, to support military healthcare programs. The contract has a completion date of January 28, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $44,648.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $18,843.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,492.54 and a performance period through May 16, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $19,188.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medical supplies, specifically 4568111982 ! ZEPBOUND 12.5MG/0.5 4S, with a performance period that extends through May 30, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition....
This federal contract award, valued at $782,258.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and is not set aside for any specific business type. The contract will support the DLA's Medical Supply Chain program, providing a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic...
This federal contract award, valued at $25,534.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, and an ultimate completion date of May 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...